Paper40565232
Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.
Guo M and 4 others. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions. Papers, record 40565232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell- and Tissue-Based Therapy | Major topic |
| Stem Cell Transplantation | Major topic |
| Humans | |
| Clinical Trials as Topic | |
| Medicine, Chinese Traditional | |
| Animals |
Source PubMed
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25126443 | Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke. | Stroke Res Treat | 2014 | https://conductscience.org/library/papers/25126443 | PubMed |
| 2 | 18075415 | Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. | Clin Nucl Med | 2007 | https://conductscience.org/library/papers/18075415 | PubMed |
| 3 | 24480430 | Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study. | Cell Transplant | 2014 | https://conductscience.org/library/papers/24480430 | PubMed |
| 4 | 34738731 | Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/34738731 | PubMed |
| 5 | 23127560 | Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. | Cell Transplant | 2013 | https://conductscience.org/library/papers/23127560 | PubMed |
| 6 | 30156755 | Autologous Endothelial Progenitor Cells Transplantation for Acute Ischemic Stroke: A 4-Year Follow-Up Study. | Stem Cells Transl Med | 2019 | https://conductscience.org/library/papers/30156755 | PubMed |
| 7 | 33036265 | Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33036265 | PubMed |
| 8 | 24304379 | Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients. | Clin Transplant | 2013 | https://conductscience.org/library/papers/24304379 | PubMed |
| 9 | 40447329 | Adapting for the future: what can we learn from REMAP-CAP and COVID-19 pandemic trials? | Thorax | 2025 | https://conductscience.org/library/papers/40447329 | PubMed |
| 10 | 35856397 | Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report. | Connect Tissue Res | 2022 | https://conductscience.org/library/papers/35856397 | PubMed |
| 11 | 35120619 | iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. | Cell Stem Cell | 2022 | https://conductscience.org/library/papers/35120619 | PubMed |
| 12 | 30586746 | A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke). | Circulation | 2019 | https://conductscience.org/library/papers/30586746 | PubMed |
| 13 | 33705413 | Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data. | PLoS One | 2021 | https://conductscience.org/library/papers/33705413 | PubMed |
| 14 | 24693196 | Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. | J Stem Cells Regen Med | 2012 | https://conductscience.org/library/papers/24693196 | PubMed |
| 15 | 40329337 | Bone marrow mesenchymal stem cells transport connexin43 via tunneling nanotubes to alleviate isopreterenol-induced myocardial hypertrophy. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40329337 | PubMed |
| 16 | 39967882 | Formation of self-assembly aggregates in traditional Chinese medicine decoctions and their application in cancer treatments. | RSC Adv | 2025 | https://conductscience.org/library/papers/39967882 | PubMed |
| 17 | 40357115 | Safety and Efficacy of CD19-Targeted Chimeric Antigen Receptor (CAR) T-cells Generated Using DNA Transposon Systems: A Meta-Analysis. | Cureus | 2025 | https://conductscience.org/library/papers/40357115 | PubMed |
| 18 | 40468398 | New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40468398 | PubMed |
| 19 | 30064455 | Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II). | J Transl Med | 2018 | https://conductscience.org/library/papers/30064455 | PubMed |
| 20 | 34587879 | MiR-218-5p Mediates Myocardial Fibrosis after Myocardial Infarction by Targeting CX43. | Curr Pharm Des | 2021 | https://conductscience.org/library/papers/34587879 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42578174 | Knowledge and attitude of Malaysian university students towards regenerative medicine therapy and their clinical implications: a cross-sectional study. | Front Genet | 2026 | https://conductscience.org/library/papers/42578174 | PubMed |
| 41596012 | Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/41596012 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40565232
GET https://conductscience.org/api/papers/v1/40565232/references?page=2